Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan
Corewell Health and Quest Diagnostics (NYSE: DGX) completed a joint venture to form Diagnostic Lab of Michigan, LLC, with Quest owning 51% and Corewell owning 49%.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Corewell Health and Quest Diagnostics (NYSE: DGX) completed a joint venture to form Diagnostic Lab of Michigan, LLC, with Quest owning 51% and Corewell owning 49%. The JV will expand access to laboratory services in Michigan and operate while existing labs continue to serve patients until a new 100,000-square-foot laboratory at Corewell Health Southfield Center opens in Q1 2027.
Quest has begun deploying its Collaborative Lab Solutions (Co-Lab) across all 21 Corewell hospitals, including supply chain, lab management, patient blood and anemia management, lab analytics and stewardship, and reference testing to support quality, innovation, access and productivity.
Positive
- Equity split set at 51% Quest / 49% Corewell
- 100,000 sq ft laboratory scheduled to open in Q1 2027
- Co-Lab services deployed across all 21 Corewell hospitals
- Existing labs to continue providing services until new facility opens
- Comprehensive services include supply chain, lab management, blood management, analytics
Negative
- None.
Details
News Market Reaction – DGX
On Jan 5, the day this news came out, DGX closed 0.17% below the previous close.
Data tracked by StockTitan Argus for the Jan 5 session.
Key Figures
- JV ownership Quest
- 51%
- Equity stake in Diagnostic Lab of Michigan, LLC
- JV ownership Corewell
- 49%
- Equity stake in Diagnostic Lab of Michigan, LLC
- Corewell hospitals
- 21 hospitals
- Hospitals covered by Quest Co-Lab management services
- Lab facility size
- 100,000 square feet
- Planned state-of-the-art laboratory in Southfield, Michigan
- Lab opening target
- Q1 2027
- Expected opening of new Southfield laboratory facility
- Share price pre-news
- $173.79
- Price before JV completion article on Jan 5, 2026
- 52-week high
- $197.55
- Pre-news 52-week high level
- Market cap
- $19,303,887,078
- Company market capitalization pre-announcement
Historical Context
-
Announcement of upcoming J.P. Morgan Healthcare Conference presentation and webcast details.
-
Collaboration to evaluate Haystack MRD ctDNA test in a phase II NSCLC trial.
-
Strategic collaboration to offer Octave’s MSDA Test through Quest’s national network.
-
Engine Capital letter regarding governance at another company listed in Quest’s news feed.
-
Board declaration of a quarterly cash dividend with set record and payment dates.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
collaborative lab solutions (co-lab) technical
reference testing technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Quest also now provides comprehensive Collaborative Lab Solutions (Co-Lab) hospital lab management services for all 21 Corewell Health hospitals
Equity ownership of the joint venture, named Diagnostic Lab of
In addition, Quest's Collaborative Lab Solutions (Co-Lab) hospital lab management services have begun to take effect across all 21 Corewell Health hospitals. Quest has also begun to deploy initiatives incorporating a comprehensive suite of Co-Lab Solutions for Corewell Health, including supply chain, lab management, patient blood and anemia management, and lab analytics and stewardship, in addition to reference testing, supporting quality, innovation access and productivity.
About Corewell Health™
People are at the heart of everything we do, and the inspiration for our legacy of outstanding outcomes, innovation, strong community partnerships, philanthropy and transparency. Corewell Health is a not-for-profit health system that provides health care and coverage with an exceptional team of 65,000+ dedicated people—including more than 12,000 physicians and advanced practice providers and more than 15,500 nurses providing care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities—and Priority Health, a provider-sponsored health plan serving more than 1.3 million members. Through experience and collaboration, we are reimagining a better, more equitable model of health and wellness. For more information, visit corewellhealth.org.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/corewell-health-and-quest-diagnostics-complete-laboratory-joint-venture-transaction-in-michigan-302652187.html
SOURCE Quest Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.